| Date | Title | Description |
| 07.10.2024 | FDA approvals and clinical advancements propel life sciences startups forward |
Alentis Therapeutics, a clinical-stage biotech company focused on developing treatments for cancer and fibrosis, has received FDA clearance for an Investigational New Drug (IND) application for ALE.P02, a novel anti-CLDN1 ADC targeting squ... |
| 22.02.2024 | Startups welcome field experts in C-level roles |
After more than a decade of building and leading Abionic, the developer of nanofluidic point-of-care diagnostic solutions for sepsis diagnostics, the company’s founder, Nicolas Durand, handed over his CEO role to Patrick Pestalozzi, who wi... |
| 13.06.2023 | The Swiss Medtech Award 2023 goes to Abionic | |
| 10.08.2022 | Abionic receives IVDR certification for its ultra-rapid Sepsis test | |
| 30.04.2021 | Clinical trial confirms Abionic’s ability to detect Sepsis earlier | |
| 30.04.2021 | Clinical trial confirms Abionic’s ability to detect Sepsis earlier | Published recently in the Critical Care Journal, the study was designed to establish performance characteristics of the PSP test in the early detection of sepsis. A total of 300 adult ICU patients at high risk of developing sepsis admitted ... |
| 26.11.2020 | Abionic launches new tool for faster triage of Covid19 patients | Since the outbreak of the Covid-19 pandemic, countries around the globe have seen increasing occupancy rates in hospitals, particularly in ICUs, and many ICUs are at or near full capacity. Patient triage, until now, has relied mostly on pat... |
| 26.11.2020 | Abionic launches new tool for faster triage of Covid19 patients | |
| 20.06.2020 | Rising out of the crisis: Where to find new markets and customers | The pandemic has upended the business models of most startups and existing companies. As the economy reopens, companies are finding that customers may have disappeared or that their spending behavior has changed. Suppliers are going out of ... |
| 20.06.2020 | Rising out of the crisis: Where to find new markets and customers | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
The pandemic has upended the business models of m... |
| 14.01.2020 | Sepsis in the Focus of Abionic's New U.S. Clinical Trial | We are pleased to share some positive news on our BOV I and BOV II portfolio company Abionic. |
| 09.01.2020 | Le sepsis dans le viseur de la nouvelle étude clinique américaine d'Abionic | L’étude se déroulera dans sept hôpitaux majeurs: Rhode Island Hospital à Providence (Rhode Island), Baystate Medical Center à Springfield (Massachusetts), Rush Medical University à Chicago (Illinois), ainsi que les Mercy Health Clinics Sain... |
| 09.01.2020 | Le sepsis dans le viseur de la nouvelle étude clinique américaine d'Abionic | Normal 0 21 false false false FR-CH X-NONE X-NONE |
| 21.09.2019 | A partnership agreement has been established between Abionic and Genentech | We are pleased to share some positive news on our BOV I and BOV II portfolio company Abionic |
| 13.09.2019 | Abionic announces successful completion of sepsis trial | |
| 06.09.2019 | Abionic was ranked among the best Swiss ‘Scale-ups’ | In the TOP 100 Swiss Startup Awards, |
| 06.09.2019 | Supporting entrepreneurs from lab to market | Normal 0 21 false false false FR-CH X-NONE X-NONE |
| 05.09.2019 | Abionic teams up with Genentech to develop rapid Asthma test | |
| 24.09.2018 | Swiss tech companies show great interest in IPOs | |
| 19.09.2018 | Eighteen finalists nominated for the «Entrepreneur of the year» award | |
| 29.06.2018 | Trois start-up en lice pour la grande finale du Prix SVC Suisse romande | |
| 19.06.2018 | Un premier IPO Day lausannois couronné de succès | |
| 18.05.2018 | First IPO Day in Lausanne on the horizon | |
| 16.05.2018 | Global visibility for Swiss startups | |
| 25.04.2018 | A new home for life sciences companies in the Canton of Vaud | |
| 28.03.2018 | Abionic raises CHF 20 million in financing | Abionic raises CHF 20 million in financing 28.03.2018 15:09, Charlotte Pichon linkedIn facebook twitter instagram youtube -->
Great news for our Venture Leaders alumnus and TOP 100 Swiss Startups in 2011-2015. Abionic announced today clo... |
| 28.03.2018 | Abionic raises CHF 20 million in financing | The EPFL spin-off develops rapid diagnostic solutions such as the abioSCOPE, a rapid diagnostic platform for clinical laboratories allowing healthcare professionals to make diagnoses from a single drop of a patient’s blood. Possible applica... |
| 28.03.2018 | Abionic Raises CHF20 Million in Series C Financing | |
| 20.12.2017 | SEF4KMU: Die acht neuen Label-Träger 2017 | |
| 10.11.2017 | "An IPO has become a serious alternative” | |
| 20.10.2017 | FDA Registration for Abionic’s Diagnostic Testing Platform | |
| 13.06.2017 | Apety remporte le Prix du Jeune Entrepreneur 2017 | |
| 31.05.2017 | World’s fastest sepsis test successfully tested in London and Zurich | |
| 24.02.2017 | Abionic to open distribution channel in the United Kingdom and Ireland | |
| 10.02.2017 | Abionic awarded twice in a week | |
| 09.01.2017 | Abionic Receives CE Mark for Sepsis and Iron Deficiency Point of Care Diagnostics | |
| 21.06.2016 | Tech Tour announces winners of the 2016 Healthtech Award in Digital Health and Medtech | |
| 11.05.2016 | Geräte für Allergiescreenings bald in Schweizer Apotheken | |
| 28.04.2016 | Swiss Economic Award: Die Finalisten sind bekannt | |
| 10.02.2016 | Almost a billion invested in Venture Kick startups | |
| 22.01.2016 | Winning start for DigitalZurich 2025 | |
| 18.11.2015 | La FIT célèbre 20 ans de soutien à l’innovation | |
| 23.09.2015 | GENILEM accorde un coaching de trois ans à trois nouvelles start-up lémaniques | |
| 18.09.2015 | LASCCO annonce un partenariat avec Abionic pour un test de sepsis en 5 minutes | |
| 17.09.2015 | Die 100 besten Startups der Schweiz gekürt | |
| 17.09.2015 | TOP100 2015: Les 100 start-up qui secouent la Suisse | |
| 17.09.2015 | TOP 100 Startup Award 2015: Second place with allergy tests | Abionic has been located in the EPFL Innovation Park in Lausanne since it was founded five years ago. Although the company has increased the number of rooms it rents on-site, space is beginning to get rather tight. The number of employees i... |
| 22.05.2015 | Abionic launched its first allergy test | |
| 17.12.2014 | The business case for Sean Parker’s $24M gift to Stanford for allergy research | Parker – best known for creating Napster, launching Facebook, and having that wicked expensive Lord of the Rings-style wedding – himself has spent his life anaphylactically allergic to foods like the ubiquitous peanut. In fact, he says his ... |
| 15.10.2014 | Abionic Closes CHF3.8M Series B Financing | Abionic, a Lausanne, Switzerland-based medical device startup, closed a CHF3.8m Series B financing round.
The round was led by MedHoldings SA with participation from BlueOcean Ventures, NE Holding, Drexel Morgan & Co. and other business... |
| 14.10.2014 | Abionic closes CHF 3.8 million Series B financing round | |
| 18.09.2014 | Swiss Top 100 Start-ups Are Selected | |
| 19.11.2013 | Vier Startups gewinnen SWISS EXCELLENCE Product Award | |
| 18.09.2013 | Housetrip erneut an die Spitze der Top 100 Start-ups gewählt | |
| 27.05.2013 | Investors have chosen Abionic as most innovative company | |
| 15.04.2013 | Abionic wins international Local to Global Award | |
| 22.02.2013 | Bilan présente le top 50 des start-up suisses | Le magazine de Suisse romande Bilan consacre la une de son dernier numéro aux start-up suisses. 50 jeunes entreprises au total sont présentées sur dix pages. Toutes ces jeunes entreprises possèdent un potentiel de croissance et sont à la re... |
| 01.02.2013 | Investment Record for EPFL Spin-offs | |
| 29.10.2012 | Top 100 Startup 2012: Housetrip auf Platz 1 | |
| 25.05.2012 | Swissto12 winner of >>venture>> 2012 | |
| 18.05.2012 | Pix4d and SWISSto12 get the final 100'000 kick | The first round of the private funding initiative focused on the quality of the business ideas presented by the two companies, which at that point in time, weren’t allowed to be established yet. In the following two rounds, both start-ups h... |
| 26.04.2012 | Seven Swiss Companies among the Red Herring Top 100 Europe | |
| 22.03.2012 | Important certification for Abionic | |
| 25.01.2012 | Top-Class Medtech Investment Partnering Event in Montreux | |
| 20.12.2011 | 2nd Innovation Roundtable addresses challenges of the MedTech industry. | |
| 15.12.2011 | Abionic représentera lEPFL pour le prix Européen Academic Enterprise | |
| 04.10.2011 | Prix Debiopharm 2011 : CHF 20000.- pour le projet le plus novateur | |
| - | The business case for Sean Parker’s $24M gift to Stanford for allergy research | Tech entrepreneur Sean Parker just pledged $24 million to Stanford University to set up a new institute for allergy research, and it comes at an important time: We might not be too far, he says, from finding a treatment that’s curative.
The... |
